Evolv Technologies (NASDAQ:EVLV) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $43.753 million which beat the analyst consensus estimate of $41.809 million by 4.65 percent. This is a 34.44 percent increase over sales of $32.544 million the same period last year.